Pediatric Vaccines Market Analysis | 2023-2028

Market Insights

The Pediatric Vaccines Market is expected to grow from USD 33.62 billion in 2022 to USD 53.21 billion by 2028 at a healthy CAGR of 7.90% during the forecast period of 2023-2028.

Wish to Get a Free Sample? Register Here.

What are pediatric vaccines?

Pediatric vaccines are biological preparations that are used to stimulate immunity against one or several diseases among children. These vaccines induce acquired immunity against ailments.

Market Drivers

Paediatric vaccines sparks children’s immune system helping them fight infections more efficiently. Some of the key drivers of the global paediatric vaccines market include:

1. Awareness regarding health benefits of vaccination: Paediatric vaccines play a vital role in preventing and even eradicating several infectious diseases like measles, mumps, rubella, polio, and whooping cough, etc. Campaigns and information via different media channels are being shared to spread awareness regarding the health benefits of vaccination in infants and children. The rising awareness is driving the demand for paediatric vaccines.
2. Government Initiatives and Immunization Programs: Countries across the globe are actively promoting childhood vaccination through vaccination programs against many important infectious diseases. These programs include vaccination schedules that mandate specific vaccines for children. Government funding plays an important role in driving paediatric vaccine adoption.
3. Growing paediatric population – With the growth in the global population, the global paediatric population also grows, leading to higher demand for vaccinations. As birth rates increase, the market for paediatric vaccines globally expands.
4. Shift towards Combination Vaccines: One vaccine and multiple protection are what people are looking for. Growing research and developments in this field are rapidly inventing combination vaccinations that offer protection against multiple diseases in a single shot. This reduces the number of injections a child has to receive. This convenience has increased the combination vaccine need.

Want to have a closer look at this report. Register Here.

Key Players

Some of the major players in the global market are-

• GlaxoSmithKline plc
• Merck Sharp & Dohme Corp.
• SANOFI
• AstraZeneca
• Pfizer, Inc.
• Zydus Cadila
• Mitsubishi Tanabe Pharma Corporation
• Panacea Biotec
• Sinovac Biotech Ltd.
• Bio-Med Pvt. Ltd.

Segments Analysis

By Product Type

The market is segmented as monovalent and multivalent. 

The monovalent segment held the larger share by product type in 2022 and is expected to maintain its dominance owing to the safety and stability associated with such vaccines coupled with the ability to develop a prompt immune response.

By Technology Type

The market is segmented as live attenuated, inactivated, subunit, toxoid, conjugate, and others. 

The conjugate segment held the largest share by technology type in 2022 and is expected to maintain its vanguard owing to the growing awareness regarding pneumococcal and meningococcal infections.

By Application Type

The market is segmented into infectious diseases, cancer, and allergy. 

The infectious disease segment held the largest share by application type in 2022 and is expected to maintain its lead on account of the rising awareness regarding infectious diseases across the globe coupled with the improving government initiatives to prevent such diseases.

By Region

North America is estimated to contribute to the largest market share over the forecast period. The largest share can be attributed to the huge R&D investments, presence of advanced healthcare infrastructure, presence of dominant market players, and high level of awareness regarding various medical conditions among the general population.

Asia-Pacific is expected to grow with the highest CAGR over the forecast period owing to the improving government initiatives to improve healthcare, especially in emerging economies such as India and China.

To know which region offers the best growth opportunities, Click Here.

Market Segmentation

The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

The market is segmented into the following categories. 

By Product Type

• Monovalent (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
• Multivalent (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)

By Technology Type

• Live Attenuated (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
• Inactivated (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
• Subunit (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
• Toxoid (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
• Conjugate (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
• Others (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)

By Application Type

• Infectious Diseases (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
• Cancer (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
• Allergy (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)

By Region

• North America (Country Analysis: the USA, Canada, and Mexico) 
• Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and Rest of Europe)
• Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and Rest of Asia-Pacific)
• Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

Research Methodology

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

Report Features

This report provides market intelligence most comprehensively. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

What Deliverables Will You Get in this Report?

Target Audience

The following is a list of the customers that the market aims to convert the most:

• Manufacturers
• Suppliers
• Distributors
• Organizations
• Government bodies

Critical Questions Answered in the Report

• What are the key trends in the market?
• How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
• What is the impact of COVID-19 on the market?
• What are the key strategies adopted by the major vendors to lead in the market?
• What is the market share of the top vendors?

Customization Option

Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to 3 players)
• SWOT analysis of key players (up to 3 players)

Competitive Benchmarking

• Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

Custom Research: 

Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.